Harriet Mayanja‐Kizza
Harriet Mayanja‐Kizza publishes mostly in Infectious Diseases, Epidemiology and Surgery, on topics such as Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis and Infectious Diseases and Tuberculosis.
- World rank
- #325,217 of 7,710,434 ranked researchers
- Rank in Uganda
- #114 of 3,724
- Works
- 328
- Citations
- 13k
- Citations per work
- 38.1
What does Harriet Mayanja‐Kizza research?
Harriet Mayanja‐Kizza's work is mostly in Medicine (60%), Immunology and Microbiology (14%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences19659.9%
- Medicine19659.9%
- Everything else8626.1%
- Life Sciences4614.0%
- Immunology and Microbiology4614.0%
- 1Infectious Diseases26% of their works
- 2Epidemiology17% of their works
- 3Surgery10% of their works
- 4Immunology9% of their works
- 5Public Health, Environmental and Occupational Health7% of their works
- 6Virology5% of their works
Research topics
- Tuberculosis Research and Epidemiology
- Mycobacterium research and diagnosis
- Infectious Diseases and Tuberculosis
- HIV Research and Treatment
- Pneumocystis jirovecii pneumonia detection and treatment
- Diagnosis and treatment of tuberculosis
- Immunodeficiency and Autoimmune Disorders
- HIV-related health complications and treatments
Which keywords describe Harriet Mayanja‐Kizza's research?
The keywords of their largest research topics: Diagnosis, Epidemiology, Immune Response, Vaccine, Mycobacterium tuberculosis, Tuberculosis, Antiretroviral Therapy and HIV.
- Inflammation
- Cardiovascular Disease
- Abdominal Tuberculosis
- Pneumocystis
- AIDS
- Spinal Epidural Abscess
- Mycobacterium avium
- HIV
- Tuberculosis
- Vaccine
- Epidemiology
- Diagnosis
- Immune Response
- Mycobacterium tuberculosis
- Antiretroviral Therapy
- HIV Infection
- Nontuberculous Mycobacteria
- Tuberculous Meningitis
- Antibodies
- Pneumonia
- Diagnostic Challenges
- Genetic Mutations
- Primary Immunodeficiency
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Diagnosis2833 topics
- Epidemiology2833 topics
- Immune Response2262 topics
- Vaccine2262 topics
- Mycobacterium tuberculosis1801 topic
- Tuberculosis1801 topic
- Antiretroviral Therapy1664 topics
- HIV892 topics
- HIV Infection772 topics
- Mycobacterium avium601 topic
- Nontuberculous Mycobacteria601 topic
- Spinal Epidural Abscess521 topic
- Tuberculous Meningitis521 topic
- AIDS461 topic
- Antibodies461 topic
- Pneumocystis431 topic
- Pneumonia431 topic
- Abdominal Tuberculosis331 topic
- Diagnostic Challenges331 topic
- Cardiovascular Disease251 topic
- Genetic Mutations251 topic
- Inflammation251 topic
- Primary Immunodeficiency251 topic
Where does Harriet Mayanja‐Kizza work?
Harriet Mayanja‐Kizza's main affiliation in the publication record is Makerere University, Uganda.
How many publications and citations does Harriet Mayanja‐Kizza have?
OpenAlex counts 328 works and 12,505 citations for Harriet Mayanja‐Kizza, an h-index of 57, ranking #325,217 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Harriet Mayanja‐Kizza. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.